Systematic review with meta-analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn's disease and ulcerative colitis controlled trials.
A CholapraneeG S HazlewoodG G KaplanL Peyrin-BirouletAshwin N AnanthakrishnanPublished in: Alimentary pharmacology & therapeutics (2017)
Anti-TNF and anti-integrin biological agents are effective in inducing mucosal healing in UC, with adalimumab being inferior to infliximab or combination therapy. Infliximab and adalimumab were similar in CD.